T. Rowe Price Associates
OCDX

T. Rowe Price Associates’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

T. Rowe Price Associates’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,489,153
Closed -$364M – 3039
2022
Q1 		$364M Sell
19,489,153
-492,505
-2% -$8.86M 0.04% 393
2021
Q4 		$427M Buy
19,981,658
+115,758
+0.6% +$2.28M 0.04% 374
2021
Q3 		$367M Buy
19,865,900
+4,069,037
+26% +$81.9M 0.03% 400
2021
Q2 		$338M Sell
15,796,863
-74,725
-0.5% -$1.52M 0.03% 428
2021
Q1 		$306M Buy
+15,871,588
New +$280M 0.03% 437

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return